For appointment call: 318 283-2177
The Delta HCV Treatment Center is a new initiative, focusing on the recognition, treatment and management of Hepatitis C. The treatment Center, located in Bastrop, Louisiana, is lead by Dr. Raj Bhandari, in collaboration with the GI Clinic, in Monroe, LA.
Unfortunately, these new medicines are very expensive ($56,000 - $80,000) for the course of the therapy. And, getting access to treatment can be a long and challenging process, that often ends unsuccessfully.
The Delta HCV Treatment Center has created a HCV Care Team, with the hope to overcome the obstacles. The team is led by a highly trained HCV clinician and includes several specialized support staff.
Lead HCV Clinician: Assesses treatment readiness, stages liver disease and treat HCV in appropriate patients.
Treatment Access Support Person: Complete documentation for prior authorization of medications. Communicates with pharmacy and patient, to facilitate treatment access.
Treatment Adherence Support Person: Educates patients on treatment, liver health and reinfection. Dispenses medications. Assesses and intervenes, to support adherence.
Primary Care Physician: Consults with lead clinician and sees patient as needed, in order to manage any complications and monitor post-treatment.
Each patient will be staged with a FibroScan (see below). The FibroScan is a non-invasive, fast and very accurate method of assessing liver fibrosis, and in the majority of cases, a liver biopsy is not necessary. The Delta HCV Treatment Center has the only FibroScan in Northeast Louisiana.
Our mission is to take the burden away from the primary care physician, of trying to access treatment for their patients, as the main challenge is medication access. At present, the HCV Treatment Center applies to all Medicare patients and private insurers. We will work very aggressively with pharmaceutical companies, etc, so that patients will have minimal or no copays, for their treatment - essentially, zero out of pocket expense.
Medicaid currently in the State of Louisiana, has very specific criteria to be approved and they are constantly changing. We will submit to the Medicaid plan everything that they need to make a determination of acceptance or denial, on the patient’s behalf. They will write the patient a letter of denial or acceptance to the patient. If approved, we will work with their pharmacy to dispense the medication and if denied you have the right to appeal.
The goal of the Center is to provide a unique, community based service, to help move towards ending the HCV epidemic.
If we can show:
Then we can present HCV Treatment Center model, to the state and hope that they will loosen the requirements, to make it easier to treat the Medicaid population, as well.
Examination with FibroScan® (transient elastography) is a technique used to assess liver stiffness (measured in kPa correlated to fibrosis) without invasive investigation. The result is immediate, it shows the condition of the liver and allows physicians to diagnose and monitor disease evolution in conjunction with treatment and collateral factors. Exam results help to anticipate various complications, as well as to monitor and assess the damage caused by conditions such as cirrhosis. The FibroScan examination is painless, quick and easy. During measurement, you feel a slight vibration on the skin at the tip of the probe.
Your physician interprets the result according to your history and underlying disease.
Who can prescribe the FibroScan® examination?
Your physician or hepatologist will indicate the most appropriate time for you to have the examination.
FibroScan may help you get approval for the new Hepatitis C treatments. In many cases FibroScan can help you and your doctor avoid the added risk and possible complications of a liver biopsy
After a successful treatment,having a yearly FibroScan can monitor your liver's recovery. Recovery from liver fibrosis may lower your long term risk of cancer. FibroScan can show you how your recovery is advancing.
A FibroScan examination might be needed if you have any of the following conditions:
Fibroscan uses "shear waves" to measure the elasticity of the liver using an improved technique called Vibration-Controlled Transient Elastography. As the shear wave passes through the liver, it is affected by the amount of scarring (fibrosis), and this is interpreted to give an accurate global assessment of the stage of fibrosis (fibrosis staging).
The proper use of shear wave velocity analysis requires control of various physical parameters to ensure an accurate, reliable, and reproducible assessment of tissue stiffness, all inherent features incorporated into the Fibroscan. The stiffer the liver the more severe the fibrosis.
Liver fibrosis is a condition of scarring and stiffness of the liver and is caused by a variety of medical conditions. The most advanced form of scarring is called cirrhosis.
Cirrhosis can result from long term liver infections or long term liver toxins in which the healthy liver tissues are slowly replaced by scar tissues. Initially the scar tissue is fine and delicate and difficult to detect but over time it becomes thicker and can start to strangle the liver. This can prevent the liver from functionally properly. This can lead to advanced, and often irreversible, liver failure. Patients with liver failure usually require a transplant. Avoidance of cirrhosis by early detection of fibrosis has been a challenge.
Using the FibroScan® 502 device, we can now routinely provide this test to all patients who have or have had chronic conditions of the liver including those patients who previously underwent treatment.
Patients who live with viral hepatitis might not have any noticeable health problems for years. However, as the years progress, scarring in the liver can build up and slowly lead to liver failure. Once that stage is reached, the patient will need a liver transplant.
With the new FibroScan technology it is now easy to measure the health of the liver and see how much scarring the hepatitis virus has caused. Knowing the stage of fibrosis can help a patient decide if they need to start a treatment plan immediately.
FibroScan® tests can be repeated regularly (e.g. every 6-12 months) without any health risks. This can help monitor the progression of a liver disease. If you are starting a treatment (e.g. for Hepatitis C), or are making lifestyle changes to lessen the severity of damage to your liver, a FibroScan will help monitor change.
& every other Thursday
& every other Thursday
Tuesday & every
Every other Friday
Every other Friday
616 South Washington | Bastrop, LA 71220 | PH: 318.283.2177